Komori
Transgenic Group (2342) · PolicyRestated

Changes in Revenue Recognition and Presentation Following Adoption of the Revenue Recognition Standard

First written in FY2022-Q2. 1 of 3 entries say "Restated". Latest entry: FY2023-Q3.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q2 – FY2023-Q32021: 120212022: 120222023: 12023
Same theme, other companies

24 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 40 companies compared. The sentences above are computed from all 40.
Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「The Company adopted the Implementation Guidance on Accounting Standard for Fair Value Measurement from the beginning of the first-quarter consolidated accounting period and decided to apply the new accounting policies prescribed by the guidance prospectively. There was no impact on the quarterly consolidated financial statements.」

    The Company reconfirmed the adoption of the Implementation Guidance on Accounting Standard for Fair Value Measurement and that it had no impact on the quarterly consolidated financial statements.
  2. FY2022-Q3Update to the Impact of Applying the Accounting StandardAnnual report

    「As a result, compared with the previous accounting treatment, for the nine-month period ended in the current third quarter, sales decreased by ¥121.576 million, cost of sales by ¥66.915 million, selling, general and administrative expenses by ¥16.931 million, and operating income, ordinary income and profit before income taxes for the quarter by ¥37.729 million each.」

    The cumulative impact of applying the Revenue Recognition Standard was updated, with sales decreasing by ¥121.576 million and operating income, ordinary income and other items decreasing by ¥37.729 million.
  3. FY2022-Q2First statedAnnual report

    「The Company adopted the Accounting Standard for Revenue Recognition (ASBJ Statement No. 29, 31 March 2020; hereinafter, the “Revenue Recognition Standard”) and other standards from the beginning of the first-quarter consolidated accounting period. Revenue is recognized at the amount expected to be received in exchange for the promised goods or services when control of those goods or services is transferred to the customer.」

    The Company adopted the Revenue Recognition Standard and other standards from the first quarter beginning on 1 April 2021, changing the identification of performance obligations under contract services, the net presentation of transactions as an agent, and the method of recognizing sales from the use of points in e-commerce. As a result, sales for the six months ended in the current second quarter decreased by ¥104.976 million, and operating income and other items decreased by ¥34.703 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Transgenic Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Changes in Revenue Recognition and Presentation Following Adoption of the Revenue Recognition Standard | TRANSGENIC GROUP INC. (2342) | Komori